Teva Pharmaceutical Industries (NYSE:TEVA) said its “Pivot to Growth” strategy has moved into its second phase, with ...

Teva Pharmaceutical Industries Ltd. TEVA had a busy week that included a major debt refinancing, a milestone shift in how its ...

Good results on Teva's lab-made antibody that blocks gluten damage raise hopes that a treatment for celiac disease may ...

In a major victory for Israeli pharmaceutical company Teva Israel, the Delhi High Court has held that a ₹1,851 crore payment ...

New findings show favorable treatment continuity for UZEDY compared to other long-acting injectables in schizophrenia, as well as oral ...

Teva Begins Trading Ordinary Shares Directly on the NYSE Teva Pharmaceutical Industries Ltd Begins Trading Ordinary Shares Directly on the NYSE, Marking a Milestone in its Pivot to Growth Strategy ...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., announced the presentation of new olanzapine LAI (TEV-'749) post hoc data from the pivotal SOLARIS Phase 3 trial as well ...

New data revealed that healthcare providers prioritize drowsiness risk, duration of available data demonstrating long-term response and drug-drug ...

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) presented post hoc data from the Phase 3 SOLARIS trial for its investigational drug TEV-'749, a once-monthly subcutaneous long-acting injectable ...

Teva Pharmaceutical Industries is launching its first global innovation platform, challenging startups to submit novel strategies to tackle seven pervasive industry hurdles that run the gamut from ...

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and trades.

Richard Francis, Teva Pharmaceuticals CEO short and pro, joins 'Power Lunch' to discuss the company's turnaround strategy, ...